Adam Lee

8PUBLICATIONS
40CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 27, 2026
Real-World Treatment Patterns and Survival in Patients with ROS1-Positive Advanced Non-Small Cell Lung Cancer in Canada and Europe.

Winson Y Cheung, Adam Lee, Helena Bote de Cabo

|Feb 24, 2026
Five-Year Clinical Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Unresectable Pleural Mesothelioma in CheckMate 743.

Arnaud Scherpereel, Paul Baas, Anna K Nowak

|Feb 13, 2026
Real-World Treatment Patterns and Survival in Patients with Advanced Non-Small Cell Lung Cancer: An Italian Retrospective Cohort Study.

Angelo Delmonte, Nicola Gentili, Andrea Roncadori

|Nov 12, 2025
A Bayesian Model Leveraging Multiple External Data Sources to Improve the Reliability of Lifetime Survival Extrapolations in Metastatic Non-Small-Cell Lung Cancer.

Daniel J Sharpe, Georgia Yates, Mohammad Ashraf Chaudhary

|Mar 13, 2025
Population-Adjusted Indirect Treatment Comparisons of Repotrectinib Among Patients with ROS1+ NSCLC.

Jürgen Wolf, Sarah Goring, Adam Lee

|Jun 29, 2023
Treatment patterns and outcomes of patients with metastatic non-small cell lung cancer in five European countries: a real-world evidence survey.

Hollie Bailey, Adam Lee, Laura Eccles

Pageof 2

Frequent Collaborators

2 joint publications

Anna K Nowak

2 joint publications

Dariusz Kowalski

2 joint publications

Aaron S Mansfield

2 joint publications

Anne S Tsao